Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (2)
- Therapeutics (2)
- Applied Statistics (1)
- Biochemistry (1)
- Biochemistry, Biophysics, and Structural Biology (1)
-
- Bioinformatics (1)
- Biomedical Engineering and Bioengineering (1)
- Biostatistics (1)
- Circulatory and Respiratory Physiology (1)
- Clinical Trials (1)
- Diagnosis (1)
- Engineering (1)
- Life Sciences (1)
- Longitudinal Data Analysis and Time Series (1)
- Medical Education (1)
- Medical Sciences (1)
- Medical Specialties (1)
- Molecular Biology (1)
- Multivariate Analysis (1)
- Physical Sciences and Mathematics (1)
- Physiological Processes (1)
- Primary Care (1)
- Statistics and Probability (1)
- Publication
- Publication Type
Articles 1 - 3 of 3
Full-Text Articles in Male Urogenital Diseases
Prostate Cancer Screening Guidelines: Providing Patient Education, Michael Burton
Prostate Cancer Screening Guidelines: Providing Patient Education, Michael Burton
Family Medicine Clerkship Student Projects
The United States Preventative Services Task Force (USPSTF) is planning to update their prostate cancer PSA screening guidelines to a category C from category D grade. This could potentially lead to confusion among both providers and patients as they have become accustomed to the previous guidelines and there has always been much discussion among providers about whether to offer the test. This project seeks to provide information to patients about the upcoming change so that they are more informed and able to better participate in discussion with their doctor about the pros and cons of PSA testing.
Studying The Optimal Scheduling For Controlling Prostate Cancer Under Intermittent Androgen Suppression, Sunil K. Dhar, Hans R. Chaudhry, Bruce G. Bukiet, Zhiming Ji, Nan Gao, Thomas W. Findley
Studying The Optimal Scheduling For Controlling Prostate Cancer Under Intermittent Androgen Suppression, Sunil K. Dhar, Hans R. Chaudhry, Bruce G. Bukiet, Zhiming Ji, Nan Gao, Thomas W. Findley
Harvard University Biostatistics Working Paper Series
This retrospective study shows that the majority of patients’ correlations between PSA and Testosterone during the on-treatment period is at least 0.90. Model-based duration calculations to control PSA levels during off-treatment are provided. There are two pairs of models. In one pair, the Generalized Linear Model and Mixed Model are both used to analyze the variability of PSA at the individual patient level by using the variable “Patient ID” as a repeated measure. In the second pair, Patient ID is not used as a repeated measure but additional baseline variables are included to analyze the variability of PSA.
Dysregulation Of Micrornas In Blood As Biomarkers For Diagnosing Prostate Cancer, Rhonda W. Daniel
Dysregulation Of Micrornas In Blood As Biomarkers For Diagnosing Prostate Cancer, Rhonda W. Daniel
Theses and Dissertations
Prostate cancer is the most common noncutaneous cancer among men, yet current diagnostic methods are insufficient and more reliable diagnostic markers need to be developed. The answer that can bridge this gap and enable more efficient diagnoses may lie in microRNAs. These small, single stranded RNA molecules impact protein expression at the translational level and regulate important cellular pathways. Dysregulation of these small RNA molecules can have tumorigenic effects on cells and lead to many types of cancers.
Currently the Prostate-Stimulating Antigen (PSA) is used as a diagnostic marker for prostate cancer. However, many factors can elevate PSA levels such …